Global Nanomaterials And Nanotechnology MarketThis research report provides detailed study accumulated to offer Latest insights about acute features of the Nanomaterials And Nanotechnology Market. The report contains different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary and SWOT analysis.It presents the 360-degree overview of the competitive landscape of the industries. Nanomaterials And Nanotechnology Market is showing steady growthand CAGR is expected to improve during the forecast period.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):BASF SEMinerals Technologies IncAMCOL InternationalLiquidia TechnologiesNanoOptoBioDelivery Sciences InternationalHosokawa Micron GroupHyperion Catalysis International IncorporatedBBI SolutionsCytodiagnosticsGoldsolNanoComposixSigma AldrichTanaka TechnologiesEastman Kodak Company

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):Carbon NanotubesNanoclaysNanofibersNanosilverOthers

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):AerospaceAutomotiveMedicalMilitaryElectronicsOthers

Global Nanomaterials And Nanotechnology Market report provides you with detailed insights, industry knowledge, market forecasts and analytics. The report on the global Nanomaterials And Nanotechnology industry also clarifies economic risks and environmental compliance. Global Nanomaterials And Nanotechnology market report assists industry enthusiasts including investors and decision makers to make confident capital investments, develop strategies, optimize their business portfolio, innovate successfully and perform safely and sustainably.

Nanomaterials And Nanotechnology Market: Regional Analysis Includes:

Major Points Covered in TOC:

Key Questions Answered in the Report Include:

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Us:

Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Contact Us:Web:www.qurateresearch.comE-mail:[emailprotected]Ph: US +13393375221, IN +919881074592

Read more:

Nanomaterials And Nanotechnology Market Report 2020 by Companies Profiles, Trend, Business Competitors, Growing Demand, Cost Structure, Developments...

Cancer, unfortunately, is widespread throughout the world. It affects millions of lives, in many different ways, on a daily basis. Before we dive into the topic of nanomedicine and nanoparticles, lets first look at the current state of cancer treatment.

Most therapeutic options for cancer are detrimental to the body They dont just kill cancer cells, they can also damage healthy tissues causing serious side effects.

Cancer chemotherapy drugs suffer from poor biodistribution and, therefore, require high doses. [1] Resistance can also develop to one or more of the drugs being used on a regular basis. This means that oncologists must continually develop new drug cocktails to keep treating their patients.

Some of the drugs used, particularly in later rounds of chemotherapy, may also be relatively ineffective.

So far, the benefits of chemotherapy have outweighed the risks but with the dawn of the age of nanomedicine and nanoparticles, the situation may soon change.

Nanomedicine is the medical application of nanotechnology. According to Johns Hopkins:

Nanomedicine can include a wide range of applications, including biosensors, tissue engineering, diagnostic devices, and many others. [It involves]harnessing nanotechnology to more effectively diagnose, treat, and prevent various diseases.

It also involves the development of new approaches to more efficiently deliver medications to the site of action with the aim of improving outcomes with less medication (and fewer medication side effects).

Nanoparticles are amongst the most promising treatment options in oncology, They have the potential to revolutionize the usual therapies by improving the usage and delivery of chemotherapy drugs [2].

The ability to control nanoparticle shape, size, and surface, as well as their ability to transport and deliver drugs to specific locations in the body, make nanoparticles highly useful in oncology[3].

Nanoparticles use has also spread to other areas of the medical world,[4] including:

Almost. Cancer is often debilitating with few treatment options that include surgery, chemotherapy, radiation, and immunotherapy. The side effects of these treatments can be detrimental to a patients way of living. They can often experience insomnia, nausea, vomiting, and weight loss among a long list of other adverse reactions [5].

With a cancer diagnosis and treatment, a patients quality of life can quickly nose-dive. But with nanomedicine, patients may experience a dramatic decrease in chemotherapy side effects, including a reduction of toxicity from the drugs used [6]. This, combined with all the other possible advantages of administering nanoparticles, makes nanomedicine an attractive new cancer therapy option.

Nanoparticles are attractive treatment options because their outer surfaces can be modified to attack specific cancer cells. They are biocompatible and biodegradable. They also offer increased stability to their drug payload[7].

Other possible advantages include:

There are three main types of nanoparticles [8] as follows:

Lipid-based nanoparticles have many advantages over other variations of nanoparticles. This accounts for their increased use in the delivery of drugs. Lipid-based nanoparticles have better biocompatibility than other nanoparticles. This means they work better with living tissue. Lipid-based nanoparticles are also more versatile, making them a better option in many therapies, like cancer treatments.

Liposomes are formulated with a wide range of natural, synthetic, and modified lipids to help them deliver drugs as well as contrast agents for medical imaging. Liposomes are used to treat cancer, fungal infections, vaccines, and more.

Polymeric nanoparticles are currently used for the following:

Polymer-based nanoparticles improve the efficiency of drugs as well as decrease drug side effects and toxicity.

Efficiently. The purpose of nanoparticles is to deliver drugs directly to the cancer cells and not the rest of the body. They are administered intravenously and are then moved around the body by the circulatory system.

Nanoparticles are designed to locate and then accumulate on the cancer tissue, penetrating through the walls of a tumor to deliver the chemotherapy drug they carry [8]. This way, the chemotherapy drug is delivered directly to the site of cancer versus distributed throughout the body. Mass distribution to both diseased and healthy tissues is usually the cause of drug side effects.

There are different methods of releasing the drugs being administered via nanomedicine [9]:

Nanoparticles can also be designed to transform under different conditions to either release or hold onto their drugs.

While widely used for cancer therapies, nanoparticles are also used for diagnostics, a type of nanomedicine referred to as nanodiagnostics[10]. Several nanoparticle formulations have already been designed for diagnostic use only. Though currently in limited use, nanodiagnostics is a growing field with imaging applications, such as use in magnetic resonance monitoring of tumor blood vessels and coronary arteries in patients.

On top of diagnostics, nanoparticles are also used in research opportunities, the treatment of cardiovascular diseases[11], and theranostics, which is a term used to describe pre-clinical research and trials of drug therapies and other treatments[12].

The production and use of nanoparticles face many challenges [13], including:

The creation process for lipid-based nanoparticles has a significant variation between each batch developed.

The manufacturing process is challenging to develop and maintain to the point that significant, quality nanoparticles can be produced.

The production of nanoparticles is time-consuming and extremely labor-intensive, requiring specialized knowledge and tools.

Nanoparticles are intended to maximize the benefit/risk ratio of therapies. Rather than causing many debilitating symptoms in the hopes of curing one disease, like current cancer treatments, nanoparticles are designed to minimize any side effects while treating that same disease.

But the technology isnt 100 percent ready for prime time yet. More research is needed and more dollars must be spent on analyzing both the effectiveness of nanomedicine as well as the long-term effects on the body.

While lipid-based nanoparticles are the most promising prospect because they are made of natural elements and have more advantages than other types of nanoparticles, they are not yet a perfect solution for drug delivery. We need more significant investments in clinical trials in both the government and private sectors to advance the technology.

Nanomedicine is used to treat a variety of different diseases and conditions, but it is in the oncology segment where nanoparticles see the most use and the most promise. To date, there are 51 nanopharmaceuticals approved for use in clinical practice[14]. More are being studied in clinical trials for cancer and other diseases.

Clearly, nanomedicine is a field to watch closely. I believe with continual research, trials, and advancements, the future of nanomedicine and nanoparticles is bright.

****

**Love our content? Want more stories about Cancer Treatments, Drug Delivery Technologies, and New Innovations? SIGN UP FOR OUR WEEKLY NEWSLETTER HERE**

****

Related content: Why Drug Discovery is So Hard and High Risk

References:

[1] Torchilin, V.P. and Lukyanov, A.N., 2003. Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug discovery today, 8(6), pp.259-266..

[2]Shi, J., Kantoff, P.W., Wooster, R. and Farokhzad, O.C., 2017. Cancer nanomedicine: progress, challenges and opportunities. Nature Reviews Cancer, 17(1), p.20.

[3] Cho, K., Wang, X.U., Nie, S. and Shin, D.M., 2008. Therapeutic nanoparticles for drug delivery in cancer. Clinical cancer research, 14(5), pp.1310-1316.

[4] Heiligtag, F.J. and Niederberger, M., 2013. The fascinating world of nanoparticle research. Materials Today, 16(7-8), pp.262-271.

[5] Griffin, A.M., Butow, P.N., Coates, A.S., Childs, A.M., Ellis, P.M., Dunn, S.M. and Tattersall, M.H.N., 1996. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Annals of oncology, 7(2), pp.189-195.

[6] Landesman-Milo, D., Ramishetti, S. and Peer, D., 2015. Nanomedicine as an emerging platform for metastatic lung cancer therapy. Cancer and Metastasis Reviews, 34(2), pp.291-301.

[7] Doane, T.L. and Burda, C., 2012. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chemical Society Reviews, 41(7), pp.2885-2911.

[8] Singh, R. and Lillard Jr, J.W., 2009. Nanoparticle-based targeted drug delivery. Experimental and molecular pathology, 86(3), pp.215-223.

[9] Mura, S., Nicolas, J. and Couvreur, P., 2013. Stimuli-responsive nanocarriers for drug delivery. Nature materials, 12(11), pp.991-1003.

[10] Baetke, S.C., Lammers, T.G.G.M. and Kiessling, F., 2015. Applications of nanoparticles for diagnosis and therapy of cancer. The British journal of radiology, 88(1054), p.20150207.

[11] Godin, B., Sakamoto, J.H., Serda, R.E., Grattoni, A., Bouamrani, A. and Ferrari, M., 2010. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends in pharmacological sciences, 31(5), pp.199-205.

[12] Lammers, T., Aime, S., Hennink, W.E., Storm, G. and Kiessling, F., 2011. Theranostic nanomedicine. Accounts of chemical research, 44(10), pp.1029-1038.

[13] Prabhakar, U., Maeda, H., Jain, R.K., Sevick-Muraca, E.M., Zamboni, W., Farokhzad, O.C., Barry, S.T., Gabizon, A., Grodzinski, P. and Blakey, D.C., 2013. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

[14] Bobo, D., Robinson, K.J., Islam, J., Thurecht, K.J. and Corrie, S.R., 2016. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharmaceutical research, 33(10), pp.2373-2387.

Read more:

The Promising Future of Nanomedicine and... - The Doctor Weighs In

DUBLIN--(BUSINESS WIRE)--The "Global Nanotechnology Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.

Owing to its wide range of uses, the global nanotechnology market is expected to grow at a CAGR of around 17% during the forecasted period of 2018-2024. Thus, there lies a great opportunity for industry participants to tap the fast-growing market, which would garner huge revenue on the back of the commercialization of the technology.

In the latest research study, Global Nanotechnology Market Outlook 2024, analysts have conducted a segmented research on the nanotechnology industry, and have interpreted the key market trends & developments that clearly highlight the areas offering promising possibilities for industries to boost their growth. In 2017, the global nanotechnology market has shown impressive growth owing to factors, like an increase in government and private sector funding for R&D, partnerships & strategic alliances between countries, and increased in demand for smaller and more powerful devices at affordable prices. At present, the healthcare industry is one of the largest sectors where nanotechnology has made major breakthroughs with its application for the diagnosis and treatment of chronic diseases like cancer, heart ailments, etc. Further, significant developments are also being done in other sectors like electronics, agriculture, and energy.

In this report, the analysts have studied the current nanotechnology market on segment basis (by application, by component and by region), so as to provide an insight on the current market scenario as well as forecasts of the aforementioned segments till 2024. The report provides an in-depth analysis of all the major segments, taking into account the major developments taking place at the global level in the respective segments that will further boost the growth of the nanotechnology market.

Further, the application section covers the use of nanotechnology in electronics, energy, cosmetics, medical, defence, and food and agriculture sectors; while the component section covers the segregation of nanotechnology market into nanomaterials, nanotools, and nanodevices.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Nanotechnology - An Introduction

4. Key Market Trends and Developments

4.1 Nanotech Tools Open Market for more Miniature Electronics

4.2 Nanotechnology Accelerating Healthcare and Medical Device Industry

4.3 International Collaborations for Nanotechnology Research

4.4 Nanotechnology Playing a Vital Role in the Growth of Energy Industry

4.5 Nanotechnology Playing a Key Role in the Growth of Food & Agriculture Industry

5. Nanotechnology Market Outlook to 2024

5.1 By Components

5.1.1 Nanomaterials

5.1.2 Nanotools

5.1.3 Nanodevices

5.2 By Major Applications

5.2.1 Electronics

5.2.2 Energy

5.2.3 Cosmetics

5.2.4 Biomedical

5.2.5 Defense

5.2.6 Food and Agriculture

6. Country-Level Analysis

6.1 US

6.1.1 Funding

6.1.2 Research & Developments

6.1.3 Regulations

6.2 Brazil

6.3 Germany

6.4 France

6.5 UK

6.6 Ireland

6.7 Russia

6.8 Japan

6.9 South Korea

6.10 Taiwan

6.11 China

6.12 India

6.13 Australia

7. Patents Analysis

8. Competitive Landscape

8.1 Altair Nanotechnologies Inc.

8.2 Nanophase Technologies Corporation

8.3 Nanosys, Inc.

8.4 Unidym, Inc. (subsidiary of WisePower Co.)

8.5 Ablynx

8.6 Zyvex Corporation

8.7 Acusphere, Inc.

8.8 Chasm Technologies, Inc.

8.9 PEN, Inc

8.10 Bruker Nano GmbH

8.11 Advanced Diamond Technologies, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ya4tqi

Visit link:

Global Nanotechnology Market Expected to Grow with a CAGR of About 17% by 2024 - ResearchAndMarkets.com - Business Wire

Researchers at the Advanced Science Research Center at The Graduate Center, CUNY (CUNY ASRC) and Northwestern University have created a 4D printer capable of constructing patterned surfaces that recreate the complexity of cell surfaces. The technology, detailed in a newly publishedpaperin Nature Communications (DOI: 10.1038/s41467-020-14990-x), allows scientists to combine organic chemistry, surface science, and nanolithography to construct precisely designed nanopatterned surfaces that are decorated with delicate organic or biological molecules. The surfaces will have a wide variety of uses, including in drug research, biosensor development, and advanced optics. Importantly, this technology can create surfaces with different materials, and these materials can be patterned across the surface without the use of expensive photomasks or tedious clean room processes.

I am often asked if Ive used this instrument to print a specific chemical or prepare a particular system, said the studys primary investigator Adam Braunschweig, a faculty member with the CUNY ASRC Nanoscience Initiative and The Graduate Center and Hunter College Chemistry Departments. My response is that weve created a new tool for performing organic chemistry on surfaces, and its usage and application are only limited by the imagination of the user and their knowledge of organic chemistry.

The printing method, called Polymer Brush Hypersurface Photolithography, combines microfluidics, organic photochemistry, and advanced nanolithography to create a mask-free printer capable of preparing multiplexed arrays of delicate organic and biological matter. The novel system overcomes a number of limitations present in other biomaterial printing techniques, allowing researchers to create 4D objects with precisely structured matter and tailored chemical composition at each voxela capability the authors refer to as hypersurface lithography.

Researchers have been working toward using lithographic techniques to pattern surfaces with biomolecules, but to date we havent developed a system sophisticated enough to construct something as complicated as a cell surface, said Daniel Valles, a Graduate Center, CUNY doctoral student in Braunschweigs lab. We envision using this system to assemble synthetic cells that allow researchers to replicate and understand the interactions that occur on living cells, which will lead to the rapid development of medicines and other bioinspired technologies.

As proof-of-concept, the researchers printed polymer brush patterns using precise doses of light to control the polymer height at each pixel. As illustrated by the Lady Liberty image, coordination between the microfluidics and the light source control the chemical composition at each pixel.

Polymer chemistry provides such a powerful set of tools, and innovations in polymer chemistry have been major drivers of technology throughout the last century, said the papers co-author Nathan Gianneschi, who is the Jacob & Rosaline Cohn Professor of Chemistry, Materials Science & Engineering, and Biomedical Engineering at Northwestern University. This work extends this innovation to the interfaces where arbitrary structures can be made in a highly controlled way, and in a way that allows us to characterize what we have made and to generalize it to other polymers.

This paper is a tour-de force demonstration of what can be done with massively parallel lithography tools, said Chad Mirkin, George B. Rathmann, Professor of Chemistry and the director of the International Institute for Nanotechnology at Northwestern Universitys Weinberg College of Arts and Sciences, who is not a coauthor of the study. The co-authors have created a powerful set of capabilities that should be heavily utilized across the chemistry, material science, and biological communities.

The researchers plan to continue development of this novel printing platform to increase system speed, reduce pixel dimensions, and develop new chemistries for increasing the scope of materials that can be patterned. Currently, they are using the patterns created by this platform to understand the subtle interactions that dictate recognition in biological systems.

This research was supported by funding from the National Science Foundation, the Department of Defense through a Multidisciplinary University Research Initiative, and the Air Force Office of Science Research.

Reference:Carbonell, C., Valles, D., Wong, A.M. et al. (2020) Polymer brush hypersurface photolithography. Nat Commun. DOI: https://doi.org/10.1038/s41467-020-14990-x

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Originally posted here:

Nanoscale 4D Printing Procedure To Drive Development of New Therapeutics - Technology Networks

Professor Alexander Quandt, acting chair of the Materials for Energy Research Group and focus area co-ordinator for the Centre of Excellence in Strong Materials, has won the Special Annual Theme Award in the National Science and Technology Forum South32 Awards (the Science Oscars) for his work on materials for inclusive economic development. His work on the theoretical foundations, numerical implementations and practical applications of state-of-the-art material simulations focuses on first principle methods, starting from a quantum mechanical description of the atoms that constitute a given material. His methods have allowed for the development of ground-breaking contributions to the field of 2D materials that play a central role in upcoming quantum technologies.

Computer experiments have finally established themselves alongsidemore traditional experimental techniques as a powerful tool to develop noveltechnologies in a very economical and systematic fashion, says Quandt. Myresearch also points out new applications of chemical elements across the wholeperiodic table, which might lead to new types of solar cells, batteries andcomputing devices [being] developed here in South Africa.

Quandt says the highlight of his research is the work on planartypes of nanomaterials similar to the so-called wonder material, graphene. Someof his research in the field pre-dated graphene and was based on boron, theimmediate neighbour of carbon in the periodic table.

The research groups I managed in the past or started recently arerole models for unconventional but nevertheless very successful and productivemulti-disciplinary research initiatives into the fields of materials scienceand energy technologies, adds Quandt. The University of the Witwatersrand hasbecome the main hub of a new trans-continental ARUA Centre of Excellence inMaterials, Energy and Nanotechnology (ARUA CoE-MEN) that is headed by LeslieCornish and myself.

Quandt is hoping that his work may ultimately lead to theestablishment of a network of highly trained graduates that will strengthen thematerials beneficiation and high-tech sectors, something that South Africasorely needs if it wants to play a role in emergent technologies.

The goal is to develop an accurate description of optical andenergy devices over multiple length scales, which start from the atomicstructure of basic materials and extend all the way to the simulation of atypical working device, says Quandt. Understanding a solar cell, a complexoptical waveguide system or a battery in virtually all of its physical andchemical aspects allows for the optimisation of existing technologies and thedevelopment of entirely new technologies.

Ultimately, Quandt believes that the development and implementationof powerful numeric simulation methods will be a key aspect in emerging fieldssuch as Industry 4.0 and Quantum Computing.

As a student I was given a copy of Linus Paulings The Nature of the Chemical Bond, and Idevoured it in one go, concludes Quandt. Paulings unique scientific style ofcombining intuition with quantum mechanical calculations and detailedexperimental studies has always been an inspiration for my own work as amaterials scientist. It was a great satisfaction to add new fundamental aspectsto one of the most esoteric chapters in his book about electron deficientmaterials.

Quandt walks away with the Special Annual Theme Award thanks to hispioneering work in computational materials science with applications tonanomaterials, optics/photonics and renewable energy research, an award wellearned indeed. Tamsin Oxford

Follow this link:

Inclusivity through innovation - Mail and Guardian

Editors note:Dr. Shedingeris a Professor of Religion at Luther College in Decorah, Iowa. He is the author of a recent book critiquing Darwinian triumphalism,The Mystery of Evolutionary Mechanisms.

No better advertisements for intelligent design exist than works written by establishment scientists that unintentionally make design arguments. I can think of few better examples than well-known cosmologist Paul Daviess recently published book The Demon in the Machine: How Hidden Webs of Information Are Solving the Mystery of Life (2019).

With a nod toward James Clerk Maxwells entropy-defying demon, Davies argues that the gulf between physics and biology is completely unbridgeable without some fundamentally new concept. Since living organisms consistently resist the ravages of entropy that all forms of inanimate matter are subject to, there must be some non-physical principle allowing living matter to consistently defy the Second Law of Thermodynamics. And for Davies there is; the demon in the machine turns out to be information.

Throughout the book, Davies marvels at the stunning complexity of life, especially at the cellular and molecular levels. He wonders at the existence of molecular machines like motors, pumps, tubes, shears, and rotors paraphernalia familiar to human engineers and their ability to manipulate information in clear and super-efficient ways, in Daviess words conjuring order out of chaos. In fact, he calls the cell a vast web of information management, observing that while molecules are physical structures, information is an abstract concept deriving from the world of human communication.

Yet despite all these analogies between the nanotechnology of life and the world of human engineering, Davies deftly ignores the obvious conclusion the nanotechnology of life must have been designed, just like human-engineered machinery. Though he tries valiantly to ignore this obvious conclusion, Davies cannot completely run and hide, for he explicitly says, It is hard not to be struck by how ingenious all this machinery is, and how astonishing that it remains intact and unchanged over billions of years. (Emphasis in the original.) Indeed! Anything so ingenious must, almost by definition, be the product of intelligence if we are not to drain the word ingenious of its meaning.

But trying to ignore the implications of his own work, Davies soldiers on with more unintentional ID statements:

Lifes ability to construct an internal representation of the world and itself to act as an agent, manipulate its environment and harness energy reflects its foundation in the rules of logic. It is also the logic of life that permits biology to explore a boundless universe of novelty.

Logic, of course, is a product of mental activity. So is Davies implying an active intelligence working at the cellular and molecular level? It appears so even if he would never admit it. Yet he does practically admit it when he throws up his hands and declares, Indeed, lifes complexity is so daunting that it is tempting to give up trying to understand it in physical terms.

If the molecular machinery of the cell has overwhelmed Davies with its sublime complexity, he is equally astounded by the field of epigenetics: In the magic puzzle box of life, epigenetic inheritance is one of the more puzzling bits of magic. He discusses the research on directed mutation by John Cairns in the 1980s, more recent work on epigenetics by Eva Jablonka, and the early work on transposition by Barbara McClintock and its flourishing in James Shapiros Natural Genetic Engineering and concludes: its tempting to imagine that biologists are glimpsing an entire shadow information-processing system at work at the epigenetic level. Tempting indeed! And lest we forget, information processing derives from and is a property of intelligence.

Finally, Davies turns to the origin of life question which he brands as almost a miracle. He agrees that chemistry alone cannot explain the origin of life because one also needs to account for the origin of information. For Davies:

Semantic information is a higher-level concept that is simply meaningless at the level of molecules. Chemistry alone, however complex, can never produce the genetic code or contextual instructions. Asking chemistry to explain coded information is like expecting computer hardware to write its own software.

The origin of coded information is, according to Davies, the toughest problem in evolutionary biology. But, of course, it is only a tough problem for those who have excluded intelligence from the equation a priori. From an ID perspective, the origin of information is no mystery at all. It is always the creation of intelligent minds, a point made consistently by Stephen Meyer.

To explain all this, Davies can do no better than to speculate that somehow new laws and principles emerge from information processing systems of sufficiently great complexity. But he entirely ignores the question of the origin of the information processing system itself, which he has already pronounced as beyond the ability of chemistry alone to explain.

It is likely that Davies would never want to align himself with the ID community. He might believe that the professional cost is just too great. But if I didnt know any better, I would swear that The Demon in the Machine had rolled right off the presses of Discovery Institute. If abstract information is truly at the root of life, then intelligence has to be factored into the equation. Davies has made a compelling case for the former, so by extension and much to his chagrin he seems to be making a compelling case for the latter.

Photo: Paul Davies, by Cmichel67 / CC BY-SA.

Read the original here:

Hey, Paul Davies Your ID Is Showing - Discovery Institute

Sherif Bechara, CEO, American Hospital at the Medical Library of the American Hospital, Oud Metha, Dubai. Image Credit: Antonin Klian Kallouche/Gulf News

Dubai: The American Hospital, Dubai has been in the forefront of healthcare delivery and innovation, having introduced the first ever robotic surgery facility recently. With its advanced centres of excellence in oncology and rehabilitation along with several facilities for gynaecology, pediatrics, urology, endocrinology and wellness, run by US and Canadian board-certified specialists, the JCI accredited hospital is looking to add research and innovation to its credit as well.

In sync with the UAEs vision for the future of healthcare and medical tourism, the hospital intends to expand its AI applications, explore nanotechnology applications that are FDA approved, and start satellite clinics for more effective and affordable health care delivery. Sherif Bechara, CEO of American Hospital in conversation with Gulf News talks about the unique qualities that make American Hospital one of the leading healthcare centers in Dubai.

Q: What is the main thrust of American Hospitals healthcare policy that sets it apart from other healthcare facilities?

A: Since its inception in 1996, American Hospital has focused on the patient and patient needs. Our focus has never been revenue and numbers. Quantity was never a priority as this comes automatically with high quality medical services. We do not place excessive emphasis on statistics, yet focus on caring for people.

Q: What are the firsts this hospital has achieved?

A: The American Hospital, Dubai was the first to perform bilateral knee and hip replacement surgeries, Functional Endoscopic Sinus Surgery (FESS) using navigation, cochlear implant and speech therapy, provide state of the art comprehensive cancer diagnostic and therapeutic treatment utilizing Positron Emission Tomography/Computed Tomography (PET/CT) scanner with the injection of Fluorodeoxyglucose (FDG), Ablation Therapy, Cardiac Electrophysiology services, laparoscopic surgery, and we had the first OR for eurospinal surgery utilizing neuronavigation with O Arm (a CT in the OR). When started in 1996, we were one of the largest private hospitals with 100 beds and kept expanding as the demand for quality healthcare grew. By 2010, we had 245 beds.

Q: How do you see American Hospital playing an important role in cancer research and care as this is one of the top non- communicable diseases here in the UAE and its growing incidence is a cause for concern?

A: We have a full-fledged oncology center that offers chemo, radio, surgical and immunotherapy services. We have initiated several internal studies on cancer research, and by June 2020 we will start an oncology Center of Excellence that will be dedicated to diagnosing and treating all kinds of pediatric and adult cancers. Our vision is to focus on extensive and latest research and development in the field of cancer. We also plan to further customize cancer treatments using Artificial Intelligence as well as targeted therapies.

Q: You have done some pioneering work in Robotics and cancer research? Can you throw some light on it?

A: Recently, in January 2020, we introduced Robotic surgery and became the first private hospital in Dubai to introduce the da Vince XI robot in UAE. Robotic surgery is currently carried out in general surgery, urology and gynecology. We have proudly conducted 18 robotic surgeries with excellent clinical outcomes. Robotic surgery is about precision and speed - the patients length of stay in hospital is reduced, so is/her surgical site infection as it is minimally invasive procedure and adds value to the patients experience and caps the cost on health insurance.

Q: What are the other noteworthy super specialties at American Hospital?

A: We have a state-of-the-art rehabilitation department that caters to both neuro and physical rehabilitations. In addition to comprehensive cardiac services ranging from diagnostic using (MRI, PET/CT, SPECT/CT, CT, Bi-Plane Cathlab with electrophysiology services, Stress Echo, Holter, Telemetry, Transtelephonic services) supported by an elite cardiac surgery team.. Not to mention that with the increasing incidence of lifestyle diseases we have an advanced endocrinology department that caters to patients of diabetes, thyroid and other hormonal disorders.

Q: What is the Unique Selling Proposition of American Hospital?

A: We place as much emphasize on preventive health as we do on treatment protocols. We have facilities for regular and comprehensive health check-ups. The unique thing about American Hospital is that not only do we have general physicians, but we also have family health doctors who are US or Canadian board-certified specialists and are well-trained & equipped to handle urgent care patients. In fact, it is a well- known fact that 70% of patients in ERs are not in for life saving but urgent care patients... We are also proud to be the first private healthcare organization in the middle east to receive JCI accreditation and to be affiliated to the Mayo Clinic Care Network.

Q: How can one make health care more affordable for the masses. Is your organization only targeting premium and privileged customers or is there something for the common man as well?

A: While we are leading in terms of facilities, research and treatments, the management of American Hospital is aware of its community responsibilities, through our charity group Al Shifa Charity Fund, we reach out to the unprivileged and extend help wherever possible.

Q: What needs to be done according to you to increase more medical tourism footfall?

A: We are completely in sync with the Dubai Medial tourism targets and feel the responsibility to invite more patients from the region to the UAE for treatment purposes. We have outreach facilities in China, Nigeria, Kuwait and Pakistan where we held roadshows. In Nigeria for instance, we have set up an office for medical tourism and intend to bring in patients from East Africa through that office. We will adopt the same strategy for other countries in South East Asia and tap into the market there. People trust, and were travelling to Europe and US for treatments, but we are steadily building the same trust in our services. We have set optimistic goals that in one-year time we will be able to translate all our efforts into a sizable traffic of medical tourists from these countries.

Q: What needs to be done to make health care insurance more relevant to the average Dubai expatriate and is there anything people can do to make insurance premiums more affordable?

A: There is a need for greater trust between healthcare and health insurance systems. While misuse of medical facilities must stop, there is also need for health care insurances to blatantly reject expenses. Instead of specific descriptions, what we need are categories and ranges that will come with the DRG system of billing soon to be implemented. This will help streamline billing and bring more transparency. Both sectors need to hold joint workshops on transparency and trust-building where common mistakes can be highlighted and both sides be educated on the best way forward.

Q: Would you say the vision of the American Hospital policymakers is in sync with that of the rulers of UAE and Dubai in particular who has laid out an elaborate plan for health care in Dubai and the UAE?

A: We are in complete harmony with the UAEs clear vision and strategy for healthcare and its sustainable goals. We too, are focusing on introducing new techniques such as robotic surgery, starting centers of excellence to accelerate the goals of healthcare delivery to the patients. We are not just looking at treatments but investing in prevention by focusing on research and development, especially in the field of cancer. We also believe that Artificial Intelligence and nanotechnology is the way forward in healthcare. Annually, by the end of 2020, the world would have spent a total of $6.6 billion on AI, and by 2026 the world will be spending $150 million a year. Our robotics and super specialty centers using Artificial Intelligence and nanotechnology will help reduce the length of stay in hospital and make treatments more cost-effective and affordable for patients.

Q: What are the plans for future expansion of the Hospital?

A: We plan to start several satellite clinics in Dubai that will cater to patients and provide services closer to home. We are planning to start three clinics, in Khawaneej, Dubai Hills and the Mira starting from April-September 2020. The satellite clinics, as the name suggests will be connected to the main Hospital. Patients seen at these clinics will be referred to the Hospital in case of an emergency or advanced treatment requirement such as surgery or oncology or rehabilitation. The purpose behind these satellite clinics is to make healthcare more accessible to people right at their doorstep.

See more here:

American Hospital in sync with UAE's vision for healthcare innovation - Gulf News

DUBLIN, Feb. 18, 2020 /PRNewswire/ -- The "Nanotechnology in Cancer Treatment" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report includes:

According to the National Science Foundation (NSF) the term nano refers to particles, structures, or devices having at least one dimension below 100 nm. Development, manufacturing, and sale of these products have spawned a multibillion industry, commonly referred to as the nanotechnology sector.

There are three main product groups of products that contribute to this industry: nanostructured materials, nanotools, and nanodevices. Nanostructured materials are materials with at least one internal, external, or surface characteristic measurable in nanometers. They include nanomaterials, nanointermediates, surface nanostructures, nanocomposites, and nanoporous materials. Nanomaterials (also called nano-objects) represent the largest category of nanostructured materials and are classified based on how many dimensions fall below 100 nm.

Technology Highlights and Market Outlook

List of TablesTable 1: The Nanotechnology IndustryTable 2: Global Market for Nanotechnology in Cancer Treatment, by Type, Through 2024Table 3: Applications of Nanotechnology in Cancer TreatmentTable 4: Current and Emerging Trends in Nanotechnology-Based Cancer TreatmentTable 5: Global Market for Cancer Drugs and Therapies Based on Nanotechnology, by Region, Through 2024

List of FiguresFigure 1: Global Market Share of Nanotechnology in Cancer Treatment, by Type, 2024Figure 2: Global Market Share for Cancer Drugs and Therapies Based on Nanotechnology, by Region, 2024

For more information about this report visit https://www.researchandmarkets.com/r/hccw6d

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/nanotechnology-in-cancer-treatment-2017-2024-current--emerging-applications-evolving-trends--patterns-strategies-adopted-by-leading-players-301006541.html

SOURCE Research and Markets

The rest is here:

Nanotechnology in Cancer Treatment 2017-2024: Current & Emerging Applications, Evolving Trends & Patterns, Strategies Adopted by Leading...

Additional Deputy Commissioner Sadashiva Prabhu said on Wednesday that more research was necessary in the field of nanotechnology as it had immense potential in various fields.

He was speaking after inaugurating a national seminar on Advances in Nanotechnology and Environmental Chemistry for Sustainable Development organised by MGM College here.

Mr. Prabhu said that nanotechnology was affecting almost all sectors, including healthcare, food processing and biotechnology. Advances in nanotechnology would also help in conservation of environment, he said.

Registrar of Manipal Academy of Higher Education (MAHE) Narayan Sabhahith said that sustainability of environment was important. Population on the planet had increased rapidly in the last 200 years.

During the ancient times, the human settlement was along the course of rivers because people needed water to survive and for other purposes also, he said.

As long as population was less, there were no problems. But with the constant increase in population leading to the present levels, this had put a strain on the rivers and water bodies, he said.

High population had led to increase in pollution, which was putting pressure on environment. It was becoming unsustainable, he said.

The other problem was consumption of resources, which would pose a problem in the future. If the 10 % of the affluent population in the world reduced their consumption of resources, sustainability could be attained, he said.

Recycling and reuse of products should be given importance. Management of waste water was a big challenge in a small city such as Udupi. Hence, waste water management should be given importance, Dr. Sabhahith said.

Associate Professor, Department of Atomic and Molecular Physics, MAHE, Suresh D. Kulkarni, delivered the keynote address. College principal M.G. Vijay presided over the inaugural function. MGM PU College principal Malati Devi was present.

Arun Kumar B. welcomed the gathering. K. Bhaskar Acharya proposed the vote of thanks.

You have reached your limit for free articles this month.

Register to The Hindu for free and get unlimited access for 30 days.

Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.

Enjoy reading as many articles as you wish without any limitations.

A select list of articles that match your interests and tastes.

Move smoothly between articles as our pages load instantly.

A one-stop-shop for seeing the latest updates, and managing your preferences.

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Visit link:

More research needed in the field of nanotechnology - The Hindu

U.S. Nanotechnology in Medical Devices Market accounted for major revenue share in 2018, owing to presence of enormous number of nanotechnologies based medical device manufacturing firms, coupled with highly developed healthcare system. Furthermore, initiation of supporting nanotechnology development programs and ongoing research activities are the factors boosting market growth.

Global Nanotechnology in Medical Devices Market value is set to achieve a significant CAGR from 2019 to 2025, as per the research study report by Global Market Insights, Inc. Nanotechnology in medical devices has applications in different areas that include diagnostic, research as well as therapeutic. Advancements in the nanotechnology aids in medication of neuro degenerative disorders that include, Alzheimers, Parkinsons disease, as well as in treatment of tuberculosis. There are also clinical applications in the fields of ophthalmology, operative dentistry, tissue engineering, immune response, antibiotic resistance, visualization, and surgery. Such wide-ranging applications boosts industry growth. Additionally, Nano pharmaceuticals are used in the detection of diseases at earlier stage, thus extensive applications are projected to propel nanotechnology in medical devices market growth.

Request for a Sample of this research report: https://www.gminsights.com/request-sample/detail/3784

Nanotechnology in Medical Devices Marketsize is expected to grow significantly from 2019 to 2025. Rising adoption of home healthcare software across the globe will drive the industry growth over forecast timeframe. Home healthcare software are easy to use, cost effective and provides accurate medical information regarding billing records, scheduling, medical history and maintenance of patient electronic medical records that increases the operational efficacy and allows home care agencies to deliver quality patient care. As a result, demand for home healthcare software is growing and scenario is likely to remain so over foreseeable future.

Nanotechnology in Medical Devices market report provides a comprehensive landscape of the industry, accurate market estimates and forecast split by product, application, technology, region and end-use. All quantitative information is covered on a regional as well as country basis. The report provides valuable strategic insights on the Nanotechnology in Medical Devices market, analyzing in detail industry impact forces including growth drivers, pitfalls and regulation evolution. The report also includes a detailed outlook on the Nanotechnology in Medical Devices market competitive environment, diving into the industry position of each major company along with the strategic landscape.

Nanotechnology in Medical Devices market report is an all-inclusive document, compiled and designed to provide best-in-class research, insightful analysis and accurate quantitative data. The coverage of this research is the most extensive when compared to other similar studies available on Nanotechnology in Medical Devices market. The industry ecosystem information presented in this report is next-to-none and aims to address all stakeholders of the industry, irrespective of their size and business function. Details of segmentation and cross reporting structure, wherever feasible, makes this Nanotechnology in Medical Devices market research one of its kind to offer the most in-depth, readily available data.

Trends, analysis, SWOT and regional coverage that is available in Nanotechnology in Medical Devices industry report offers market intelligence that help readers in strategic choices that business demands. Moreover, this research can be tweaked to cover specific requirements of a client or completely customized for a particular company.

Nanotechnology in Medical Devices Market by Product, 2014-2025 (USD Million)

Nanotechnology in Medical Devices Market byApplication, 2014-2025 (USD Million)

More Insightful Info: https://www.marketwatch.com/press-release/global-nanotechnology-in-medical-devices-market-applications-2019trends-size-and-share-till-2025-2019-10-04

The data in this Nanotechnology in Medical Devices market research is collated via multiple channels including but not limited to primary and secondary sources, databases, business specific references and others. The study aims to offer not only commercial data but also includes analysis of important factors, technical as well as market-oriented insights. Players in the Nanotechnology in Medical Devices market including established companies, new entrants and everyone in between this industry chain covering suppliers, experts, manufacturers, service providers, traders, distributors, consumers / clients and others may find value in this research.

Related Insightful Reports:

Artificial Organs Market: https://www.marketwatch.com/press-release/artificial-organs-market-size-growth-opportunity-and-forecast-to-2025-2020-02-17

Cardiac Arrhythmia Monitoring Devices Market: https://www.marketwatch.com/press-release/cardiac-arrhythmia-monitoring-devices-market-size-growth-opportunity-and-forecast-to-2025-2020-02-17

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: [emailprotected]

See the original post:

Nanotechnology in Medical Devices Market 2019: Insights and Forecast Research Report 2025 - Technology Magazine

Nanotechnology will transform our lifes, our economy, our future. The book of the Oxford professor of biological physics, Sonia Contera, Nano Comes To Life: How Nanotechnology Is Transforming Medicine and the Future of Biology (Amazon.com, Amazon.co.uk, Amazon.de, Amazon.fr), explains why and how.

Nanotechnologies allow scientists to visualize, interact with, manipulate and create matter at the nanometer scale. Nanotechnology can manipulate the building blocks of life and, therefore, life itself because proteins and DNA are nano-size.

According to Sonia Contera, health and longevity will be affected. Nanoscale machines can target individual cancer cells and deliver drugs more effectively. Nanoantibiotics can fight resistant bacteria and makes it possible to engineer tissues and organs for research, drug discovery and transplantation.

Nanotechnology directly links the macroscopic world of our perceptions with the nanoscopic world of individual biomolecules. To restore humans to perfect health, we would need to know how molecules work in a specific environment, why and how they malfunction in a desease and who to reach them, target them, deactivate or activate them. To cure, we need to go from the macroscopic size of the doctor to the nanometer scale of biomolecules. Sonia Conteras book tries to show how far we have come so far.

Nanotechnology has attracted physical scientists to biology. In the last decades of the 20th century, artificial nanomaterials and the tools of nanotechnology came into existence. Physcial scientists sought to know how and why biology first constructed itself using nano-size building blocks in the medium of (salty) water. The coupling of physics and chemistry give rise to biological function. Scientists focused on using nanotechnologys methods to learn the workings of proteins, DNA and other important nano-size biomolecules. They became biological physicists. Others, more practical, saw opportunities to design nanomaterials that could be used to address disease, improving on current pharmacological treatments; they became nanomedicine scientists.

Cross-disciplinary activity led to the development of tools specifically built for studying biological processes and their nano-actors in physiological conditions. Nano-bioscientists eroded the boundaries between materials sciences, physics, chemistry and biology.

The last decades saw the emergence of quantitative biology. Physicists try to create mathematical models of biological processes. They try to predict the behavior of specific biological processes in the computer (in silico), without experiments. This shall allow to progressively abandon the trial-and-error methods of the traditional biological, medical and pharmacological sciences which are slow, costly and often lead to inefficient new drugs.

Biological physics, the help of algorithms, the analysis of biological big data and AI will lead to increasingly (more) accurate and smart models of life. However, knowing the workings of the building blocks (of life) is not enough to predict the behaviour of the whole: at larger scales, biology exhibits behaviors that the smaller constituents do not exhibit, or that cannot be explained from the relationships between their molecular building blocks. Sonia Contera explains that this is because complexly organized matter presents collective phenomena arising from cooperative interactions between the building blocks (these properties emerge). Examples are cellular movements, mechanical vibrations in the brain, electrical signaling across the membranes of cells, changes in the shape or stiffness, none of which can be predicted from just knowing the molecules that constitute a particular structure. For instance, nanotechnology would allow simultanously targeting the molecular, the cellular and the issue-level biology of a tumor.

Biology, mathematics, physics and engineering sciences used in nanotechnology will radically change, the way we find, interpret and treat disease. Nanotechnology will transform biology and medicine. Sonia Contera explores the complexity of biology, the birth of DNA technology, DNA nanorobotics, nanomedicine, recreating tissues and organs, addresses issues such as fear of technology, technology and equality. These are just a few take-aways from this substantial book written for non-specialists.

The author writes that we as human beings have no other choice than to mature to become part of the whole in a physical, economic and social sense. We have to advance into the construction of a new relationship with nature that allows our survival.

Sonia Contera: Nano Comes To Life: How Nanotechnology Is Transforming Medicine and the Future of Biology. Hardcover, Princeton University Press, November 2019, 216 pages. Order the book, the source for this article, from Amazon.com, Amazon.co.uk, Amazon.de, Amazon.fr.

For a better reading, quotations and partial quotations in this book review are not put between quotation marks.

Book review added on February 14, 2020 at 16:14 German time.

Read the rest here:

How nanotechnology is transforming medicine and the future of biology - Cosmopolis

A leading research firm, Zion Market Research added a latest industry report on "Global Nanotechnology in Medical Devices Market" consisting of 110+ pages during the forecast period and Nanotechnology in Medical Devices Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Nanotechnology in Medical Devices Market.

According to the report the Global Nanotechnology in Medical Devices Market Is Expected To Reach Around USD 15.78 Billion By 2025

The Nanotechnology in Medical Devices Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. The report covers the global Nanotechnology in Medical Devices Market performance in terms of revenue contribution from various segments and includes a detailed analysis of key trends, drivers, restraints, and opportunities influencing revenue growth of the global consumer electronics market.This report studies the global Nanotechnology in Medical Devices Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Nanotechnology in Medical Devices Market by companies, region, type and end-use industry.

Request a Free Sample Report on Nanotechnology in Medical Devices Market:https://www.zionmarketresearch.com/sample/nanotechnology-medical-devices-market

The Nanotechnology in Medical Devices Market report mainly includes the major company profiles with their annual sales & revenue, business strategies, company major products, profits, industry growth parameters, industry contribution on global and regional level.This report covers the global Nanotechnology in Medical Devices Market performance in terms of value and volume contribution. This section also includes major company analysis of key trends, drivers, restraints, challenges, and opportunities, which are influencing the global Nanotechnology in Medical Devices Market. Impact analysis of key growth drivers and restraints, based on the weighted average model, is included in this report to better equip clients with crystal clear decision-making insights.

The Nanotechnology in Medical Devices Market research report mainly segmented into types, applications and regions.The market overview section highlights the Nanotechnology in Medical Devices Market definition, taxonomy, and an overview of the parent market across the globe and region wise.To provide better understanding of the global Nanotechnology in Medical Devices Market, the report includes in-depth analysis of drivers, restraints, and trends in all major regions namely, Asia Pacific, North America, Europe, Latin America and the Middle East & Africa, which influence the current market scenario and future status of the global Nanotechnology in Medical Devices Market over the forecast period.

Get Free PDF Brochure of this Report: https://www.zionmarketresearch.com/requestbrochure/nanotechnology-medical-devices-market

The Nanotechnology in Medical Devices Market report provides company market size, share analysis in order to give a broader overview of the key players in the market. Additionally, the report also includes key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market on the global and regional basis.

Major Company Profiles Covered in This Report:

GE Global Research, Merck KGaA, Ferro, AMAG Pharmaceuticals, Capsulution Nanoscience, AstraZeneca, Affymetrix, PerkinElmer, 3M, Starkey Hearing Technologies, Smith & Nephew, St. Jude Medical, Acusphere, and Stryker Corporation

Some of the major objectives of this report:

1) To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Nanotechnology in Medical Devices Market.

2. To provide insights about factors affecting the market growth. To analyze the Nanotechnology in Medical Devices Market based on various factors- price analysis, supply chain analysis, porter five force analysis etc.

3. To provide historical and forecast revenue of the Nanotechnology in Medical Devices Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.

4. Country level analysis of the market with respect to the current market size and future prospective.

5. To provide country level analysis of the market for segment by application, product type and sub-segments.

6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

7. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Nanotechnology in Medical Devices Market.

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the clients needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

244 Fifth Avenue, Suite N202

New York, 10001, United States

Tel: +49-322 210 92714

USA/Canada Toll Free No.1-855-465-4651

Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Sorry! The Author has not filled his profile.

See the article here:

Global Nanotechnology in Medical Devices Market Is Expected To Reach Around USD 15.78 Billion By 2025 - Daily News Journal USA

Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.

Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.

Excerpt from:

NIOSH: Nano- and Microplastics in the Workplace - The National Law Review

Vin Diesel, a well-known Hollywood actor and known for his life, always remains in the headlines due to his films. While the popular actor Vinis in the lead in the Hollywood film Bloodshot. Viewers see his superhero look in the trailer. In the trailer, he is seen as a soldier who dies. With the help of nanotechnology, he comes back again. The film is based on the best-selling comic book of the same name.

According to media reports, the English trailer of the film has been launched last month. The trailer has received good response worldwide. However, since the arrival of the Hindi trailer, the trend of the Indian audience has increased even more. Talking about the Hindi dubbing of the unfolded trailer, it is very close to the original trailer. Although at some places the synergy of voice and artist does not feel accurate, Hindi dialogues feel somewhat lighter than English dialogues. Although dubbing is not 100% possible.

There seems to be a scope to try something else in the Hindi trailer. The film is directed by Dave Wilson. Apart from Vin, the film stars Sam Hagen, Guy Pearce, Ija Gonzalez and Toby Kebbell in important roles. Talking about the special aspects of the trailer,there are other fighterswho are sometimes seen fighting with Vin and sometimes executing the mission with him. He is seen in tremendous action avatar throughout the trailer. At first glance, the film seems to revolve around the power of technology and its consequences. The film will be released on 13 March 2020 in India by Sony Pictures Entertainment India.

Vin Diesel, a well-known Hollywood actor and known for his life, always remains in the headlines due to his films. While the popular actor Vinis in the lead in the Hollywood film Bloodshot. Viewers see his superhero look in the trailer. In the trailer, he is seen as a soldier who dies. With the help of nanotechnology, he comes back again. The film is based on the best-selling comic book of the same name.

According to media reports, the English trailer of the film has been launched last month. The trailer has received good response worldwide. However, since the arrival of the Hindi trailer, the trend of the Indian audience has increased even more. Talking about the Hindi dubbing of the unfolded trailer, it is very close to the original trailer. Although at some places the synergy of voice and artist does not feel accurate, Hindi dialogues feel somewhat lighter than English dialogues. Although dubbing is not 100% possible.

There seems to be a scope to try something else in the Hindi trailer. The film is directed by Dave Wilson. Apart from Vin, the film stars Sam Hagen, Guy Pearce, Ija Gonzalez and Toby Kebbell in important roles. Talking about the special aspects of the trailer,there are other fighterswho are sometimes seen fighting with Vin and sometimes executing the mission with him. He is seen in tremendous action avatar throughout the trailer. At first glance, the film seems to revolve around the power of technology and its consequences. The film will be released on 13 March 2020 in India by Sony Pictures Entertainment India.

Follow this link:

Vin Diesel is an important character of this Hollywood movie, based on Nanotechnology - News Track English

Vancouver, British Columbia--(Newsfile Corp. - February 20, 2020) - Sixth Wave Innovations Inc. (CSE: SIXW) (OTC Pink: ATURF) (FSE: AHUH) (the "Company" or "Sixth Wave") is pleased to announce results of pilot scale testing of its AffinityTM system for the remediation of CBD distillate (the "AffinityTM System") with a major North American hemp processer (the "Test Partner").

The purpose of the testing has been to customize the AffinityTM System to the production of cannabidiol ("CBD") distillate, free from all detectable THC content ("T-Free Distillate") while retaining all of the other valuable cannabinoids. The objective is an important one for CBD processors, since chromatography, the legacy technology for removing THC is widely considered to have significant issues regarding capital and operating costs, efficiency, and scalability.

On December 20, 2018, the United States Agricultural Improvement Act of 2018 (the "2018 Farm Bill") established that cannabis plants and derivatives containing less than 0.3% THC would no longer be controlled substances under United States federal law and allows for federally-sanctioned hemp production under the purview of the United States Department of Agriculture (the "USDA"), in coordination with state departments of agriculture that elect to have primary regulatory authority. Products which meet the acceptable percentage of THC are considered to be compliant ("T-Compliant"). Products which have below "non-detectable" amounts of THC are considered to be T-free ("T-Free"). The testing team has been tailoring the AffinityTM unit to the production of T-Free as well as T-Compliant CBD distillate.

Pilot Scale Summary

Figure 1

To view an enhanced version of Figure 1, please visit:https://orders.newsfilecorp.com/files/5010/52592_54f3c90674e6e860_001full.jpg

The forgoing graph displays indicative results of the in-house testing and provides a comparative analysis of the AffinityTM System remediation capabilities when compared directly to distillate that was remediated using traditional chromatography. The CBD distillate generated by the AffinityTM System contained roughly half the amount of undesirable THC relative to that which was produced by chromatography.

"These results showcase the superior selectivity and extractive capabilities of the AffinityTM System versus chromatography," said Dr. Jonathan Gluckman, President and CEO of Sixth Wave. "I'm very excited and proud of the Sixth Wave team and their ability to rapidly pivot to meet the changing demands of the cannabis/hemp industry. As we know, a major challenge for the cannabinoid purification industry will be the delivery of customization and flexibility, with medicinal and recreational applications demanding exceptional product diversity. The AffinityTM System is highly capable in this regard, with the potential to tailor extraction media to recover any one of the hundreds of cannabinoids available to us. Our current accomplishment in delivering a T-Free distillate at an industrial scale is important, but is only scratching the surface of our capabilities in the cannabis sector."

AffinityTM Pilot Project and Production Unit Design

The AffinityTM pilot project is the culmination of a collaboration between Sixth Wave and numerous test partners encompassing an extensive range of specialties including polymer bead design, bead production scale-up, machine design, and cannabinoid extraction. The team notably includes; Don Riley, Affinity Farms; Aris Kalivretenos, Aurora Analytics; Billy Chavis, Paragon Processing LLC and Earl Ross, Natural Ascent Consulting. The resulting work has been useful in optimizing the performance of the AffinityTM System and is breaking new ground in the materials detection and extraction nanotechnology sector. The AffinityTM development process has comprised over 85 experiments to date with more than 30 data elements analyzed per experiment. The resultant 2,550 data elements have furnished a broad sample set for the determination of operating parameters for optimized system performance.

Story continues

Sixth Wave is now incorporating these variables into the design of AffinityTM production units. Fluid dynamics are a key component of the unit design. Work has involved the careful analysis of fluid dispersion, homogenization, and backpressure as it relates to AffinityTM bead particle size and type, all of which affect the performance of the system. Varying ethanol/water mixtures, distillate dilution ratios, flow rates, and fluid volumes are being incorporated into the current set of standard operating parameters ("SOP").

Based on these results, the Company is now progressing to Production Scale operations. The decision to accelerate production followed a series of successful bead formulations, each one unlocking the pathway to the next generation Molecular Imprinted Polymer ("MIP") design and quantitative improvements in THC remediation. The Company is in the process of collecting and analyzing the performance data essential for refining the design and starting the full-scale production process of the AffinityTM systems.

The AffinityTM Advantage

Comparative results between AffinityTM and chromatography show AffinityTM exceeding chromatography performance in terms of product retention and yield, as well as significant savings in both capital and operating costs. While the main focus of the test work has been on THC remediation, Sixth Wave has already demonstrated that the AffinityTM System can be used as a direct cannabinoid isolation and purification technology and may eliminate distillation when processing both raw crude extracts and refined distillates.

The foregoing factors are particularly important for cannabis processors focused on the vape and edibles markets. In such cases, the creation of a mixed cannabinoid isolate is an intermediate step to making products reliably dosed and easily adsorbed by the body. In turn, the ability to take crude extracts, separate the major lipids with precipitation and filtration, rather than full winterization, and process these directly with the AffinityTM System provides a major advantage in terms of THC and CBD content yield, as well as prospective savings to the operator in terms of up front equipment costs and ongoing operating costs.

In addition to the foregoing, laboratory work with extracts containing heavy metals indicate that the AffinityTM System may isolate and remove the cannabinoids without carrying forward the metal contaminants. Testing of the ability to remove pesticide contaminants is also underway. As a result of these tests, the Company has begun negotiations with several cannabis producers for pre-production deployment of AffinityTM Systems.

"Plant genetics are being manipulated successfully to increase the production of target cannabinoids at the exclusion of others," commented Dr. Gluckman, "Our ability to stay ahead of the genetics in the ability to maximize the extraction and isolation of these cannabinoids will be a key to success. As demonstrated by our successes to date, we are confident that we will continue to offer our customers cutting edge nanotechnology solutions to meet these changes and maintain their competitive advantages".

Additions to Development Team

The Company further reports on the addition of Natural Ascent Consulting ("NAC") to its development team. Co-owned by Kameron Walker and Earl Ross, NAC brings over 5 years of hemp and cannabis specific industry experience to the AffinityTM team.

Kameron Walker is a widely known expert in industrial-scale extraction and purification for both hemp and cannabis. His cannabinoid processing industry contact network is extensive, comprising all major equipment manufacturers and service companies. Kameron has aided in the early-stage and advanced development of a wide range of technologies including centrifuges, chilling systems, solvent recovery, distillation, and others.

Earl Ross is classically trained as a chemical engineer, graduating from The Pennsylvania State University in 2010. From analytical chemistry in a lab setting, to data acquisition as a field engineer in the oilfields, and finally breaking out and consulting on extraction and analytical chemistry in the hemp and cannabis industry, Earl has a multitude of industry experiences to draw upon to find solutions to emerging challenges now facing the rapidly growing hemp and cannabis industries.

About Sixth Wave

Sixth Wave is a development stage nanotechnology company focused on extraction and detection of target substances at the molecular level using its patented technologies in the highly specialized field of molecularly imprinted polymers. Sixth Wave is in the process of commercializing IXOS, a line of extraction polymers for the gold mining industry, and together with the Company, it has developed extraction polymers for the extraction of CBD, THC and other cannabinoids from cannabis extracts under the name AffinityTM.

For more information about Sixth Wave, please visit our web site at: http://www.sixthwave.com

ON BEHALF OF THE BOARD OF DIRECTORS

"Jon Gluckman"Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company:Phone: (801) 582-0559E-mail: info@sixthwave.com

Cautionary Notes

This press release includes certain statements that may be deemed "forward-looking statements" including statements regarding the AffinityTM System scale-up, THC remediation performance and commencement of full-scale production. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, including the risks that AffinityTM System performance may not be maintained at production level, that anticipated cost savings and performance levels relative to competing technologies may not be realized, that other technologies with better performance or costs may be developed by competitors, or that the regulatory regime related to cannabis and hemp, which has evolved rapidly, may change in a manner adverse to the Company's business, and other risks detailed in the Company's filing statement available at http://www.sedar.com, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52592

More here:

Sixth Wave Announces Successful Pilot Scale Testing of Affinity(TM) CBD Platform - Yahoo Finance

Organic Skin Care Market

TheOrganic Skin Care Marketrecently Published a Global Market research study with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed TOC on Organic Skin Care Market.The report provides information and the advancing business series information in the sector to the exchange. The report gives an idea associated with the advancement of this market development of significant players in this industry. An examination of this Organic Skin Care market relies upon aims, which are of coordinated into market analysis, are incorporated into the reports.

Top Companies in the Global Organic Skin Care MarketAveda Corporation, The Body Shop International, Burts Bee, Estee Lauder, The Hain Celestial Group, Yves Rocher, Amway, Bare Escentuals, Arbonne International, Kiehls, Natura Cosmticos, LOccitane en Provence.

The global organic skin care market is expected to grow with a value CAGR of +8.1% over the forecast period 2019-2025.

Market OverviewIn the current market scenario, consumers are constantly seeking eco-friendly, ethically labelled products which are free from harsh chemicals they believe to be bad for their health and environment. This is a major factor for the growth of organic skin care market across the globe.Highly populated countries like India, Brazil and Mexico have an increased purchasing power and thus, leading to the overall growth in purchasing of organic skin care products. Such countries are also establishing a favorable regulatory environment for investments in organic skin care products.

Get Sample PDF Copy of Latest Research on Organic Skin Care Market 2019https://www.marketinsightsreports.com/reports/03141148110/global-organic-skin-care-market-insights-forecast-to-2025/inquiry?Mode=46&Source=NT

Market InsightsEmerging Nanotechnology Applications in Personal Care Products to Drive Organic Skin Care MarketNanotechnology is one of the biggest hope of the mankind for a technological progress in the 21st century. Skin care is one of the most prominent fields where nanotechnology is being enthusiastically introduced.Nanotechnology is frequently used in many cosmetic products, such as moisturizers, hair care products, make up and sunscreen. With the help of encapsulation using nanotechnology, newer structures being formulated can provide better hydration of skin, stability of the agent, bioavailability and controlled occlusion.

North America Holds Largest Demand in Organic Skin Care MarketNorth America was the largest market for organic skin care care in 2017. The trend is poised to continue over the forecast period. The growth of the market can be attributed to rising demand for safe and natural products. Over the past few years, companies have been introducing new and innovative products that are designed to cater to specific consumer needs. Major players in organic skin care industry such as LOral, The Body Shop, and Este Lauder launched several organic products that target the ageing population.

The Organic Skin Care market can be divided based on product types and its sub-type, major applications and Third Party usage area, and important regions.

This report segments the global Organic Skin Care Market on the basis ofTypesareFace Creams, Body Lotion

On The basis Of Application, the Global Organic Skin Care Market is Segmented intoBaby, Teenagers, Adults, The Old

Exclusive discount on this reportInquire for Discounthttps://www.marketinsightsreports.com/reports/03141148110/global-organic-skin-care-market-insights-forecast-to-2025/discount?Mode=46&Source=NT

Regions Are covered By Organic Skin Care Market Report 2019 To 2025.North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia).

Impact of the Organic Skin Care market report:

Comprehensive evaluation of all opportunities and risks in the market. Organic Skin Care market ongoing developments and significant occasions. Detailed study of business techniques for development of the market-driving players. Conclusive study about the improvement plot of market for approaching years. Top to bottom appreciation of market-express drivers, targets and major littler scale markets. Favorable impression inside imperative mechanical and publicize latest examples striking the market.

The report has 150 tables and figures browse the report description and TOChttps://www.marketinsightsreports.com/reports/03141148110/global-organic-skin-care-market-insights-forecast-to-2025?Mode=46&Source=NT

We Also Offer Customization on report based on specific client RequirementFree country Level analysis for any 5 countries of your choice.Free Competitive analysis of any 5 key market players.Free 40 analyst hours to cover any other data point.

ABOUT US

Market Insights Reports is an online market research reports library of 500,000 in-depth studies of over 5000 micro markets. Market Insights Reports offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact Us

Irfan Tamboli Market Insights ReportsPhone: + 1704 266 3234 | +91-750-707-8687[emailprotected]|[emailprotected]

Go here to read the rest:

Organic Skin Care Market Competitive Research And Precise Outlook 2019 To 2025 - News Times

Computer Vision AI for a safer driving experience. Eye openess, angle of vision, head position... An algorithm analyses the actions of the driver and warns them in the event of distraction or drowsiness. SEAT has teamed up with the startup Eyesight Technologiesto work on adapting this driver monitoring system in its cars. "Our software is a key to safety," says Tal Krzypow, the Vice-president of Product atEyesight Technologies.

Light control at the touch of a button. A new active glazing technology by Gauzy enables users to darken or lighten the glass of the windscreen, side windows or sunroof on demand. "We are the only material science company working with both SPD and Liquid Crystal based nanotechnology. Both technologies allow glass to shift to shaded or opaque for a custom user experience, and back to transparent instantly for driving,"says Adrian Lofer, a cofounder and CTO of the nanotechnology business Gauzy which is collaborating with SEAT.

In the Silicon Valley of the Middle East. Gauzybegan in the kitchen of one of its founders, who was looking for a way to make windows more private. Today, Gauzy has more than 100 employees. Like them, there are 6,600 startups, 800 of which are dedicated to the automotive industry.

Xploringleading edge technology.In just two years, SEAT has worked with more than 200 emerging Israeli businesses through Xplora. The team responsible for Innovation at SEAT is especially looking for solutions that enhance well-being and safety, cybersecurity, sustainability and artificial intelligence. "If we want to shape the future, we have to be in the most innovative ecosystems," says Stefan Ilijevic, the head of Product innovation at SEAT.

Video - https://www.youtube.com/watch?v=_-pXiI4LeGkPhoto - https://mma.prnewswire.com/media/1091266/SEAT_Computer_Vision_AI.jpgPhoto - https://mma.prnewswire.com/media/1091267/SEAT_Gauzy.jpgPhoto - https://mma.prnewswire.com/media/1091268/SEAT_Eyesight_software.jpgLogo - https://mma.prnewswire.com/media/797359/SEAT_Logo.jpg

https://www.seat.co.uk/

SOURCE SEAT

See the article here:

This Is How SEAT Explores the Future - PR Newswire UK

Posted February 18, 2020 Atlanta, GA

After more than seven years of shepherding interdisciplinary materials research and defining a materials innovation ecosystem at the Georgia Institute of Technology, David L. McDowell is stepping down from his role as founding director of the Institute for Materials (IMat).

McDowell is the Carter N. Paden Jr. Distinguished Chair in Metals Processing and a Regents Professor. He holds a dual appointment in the George W. Woodruff School of Mechanical Engineering (ME) and the School of Materials Science and Engineering (MSE).

IMat was founded in Fall 2012 and formally launched in June 2013 in conjunction with a press release from the White House Office of Science and Technology Policy highlighting Georgia Techs commitment to the U.S. Materials Genome Initiative. IMat serves a community of more than 200 faculty and staff conducting materials-related research that bridges across all colleges and academic units at Georgia Tech, including the Georgia Tech Research Institute. IMats goal is to develop a materials innovation ecosystem to help define and pursue current and future science and technology challenges that require a multifaceted and collaborative approach.

McDowell was an early believer in the interdisciplinary approach to research. Serving as associate director (1984-1992) and director (1992-2012) of the Mechanical Properties Research Lab at Georgia Tech, he helped the facility grow into an umbrella organization that coordinates shared equipment use, training, and maintenance among campus researchers working in structural materials.

Under his leadership, and in partnership with the Institute for Electronics and Nanotechnology as well as key academic units such as MSE, IMat merged several characterization and analysis laboratories on campus into the Materials Characterization Facility (MCF). In 2019, the MCF supported more than 650 unique campus and external users in materials research, making high-end characterization tools and staff resources available to academic, industry, and government users.

McDowell has also emphasized IMats pursuit of Georgia Techs leadership in the emerging field of materials data science to enhance basic research and substantially accelerate the discovery and development of new and improved materials.

Traditional experimental methods are expensive and time consuming, slowing down the materials R&D enterprise. McDowell sees the need to apply such new methods in materials discovery and development as critical to U.S. competitiveness of basic research and insertion of materials into products. Through a strategy of identifying key faculty hires in academic units and investing in a thought leadership position among academic institutions, IMat has built a foundation for Georgia Techs highly visible efforts in this area.

In particular, the concept of a materials innovation ecosystem pursued by Georgia Tech has fostered significant cross-disciplinary research and education efforts.

We thank Dave McDowell for everything he has done to advance interdisciplinary materials research at Georgia Tech over the past seven years as the founding director of the Institute for Materials, said Raheem Beyah, vice president for interdisciplinary research. His focus on materials data science was far-sighted and has helped make us a leader in this area.

Although McDowell is stepping down from the directorship of IMat, he has no plans on leaving Georgia Tech. What has kept me in the academic realm is my love for the development of students, and in particular graduate students, developing them as people and helping them realize their goals and dreams, McDowell said. He will continue to teach to, and learn from, the next generation of leaders at Georgia Tech.

Research NewsGeorgia Institute of Technology177 North AvenueAtlanta, Georgia 30332-0181 USA

Media Relations Contact: John Toon (404-894-6986) (jtoon@gatech.edu).

Writer: Christa Ernst

Read more:

Dave McDowell to Step Down as Director of the Institute for Materials (IMat) | Research Horizons - Research Horizons

Nanotechnology Drug Delivery Market research Report is a valuable supply of perceptive information for business strategists. This Nanotechnology Drug Delivery Market study provides comprehensive data which enlarge the understanding, scope and application of this report.

A specific study of competitive landscape of the global Nanotechnology Drug Delivery Market has alloted, providing insights into the corporate profiles, financial standing, recent developments, mergers and acquisitions, and therefore the SWOT analysis. This analysis report will provides a transparent plan to readers concern regarding the general market situation to further choose on this market projects.

Get Sample Copy of this Report @ https://www.reportsintellect.com/sample-request/973672

The Nanotechnology Drug Delivery Market report profiles the following companies, which includes: AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd

You get the detailed analysis of the current market scenario for Network Access Control (Nac) Solutions and a market forecast till 2026 with this report. The forecast is also supported with the elements affecting the market dynamics for the forecast period. This report also details the information related to geographic trends, competitive scenarios and opportunities in the Network Access Control (Nac) Solutions market. The report is also equipped with SWOT analysis and value chain for the companies which are profiled in this report.

By Types: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others

By Applications: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Other Applications

Get a Good Amount of Discount @ https://www.reportsintellect.com/discount-request/973672

Overview of the chapters analysing the global Nanotechnology Drug Delivery Market in detail:

Reasons why you should buy this report

About Us:-Reports Intellect is your one-stop solution for everything associated with marketing research and market intelligence. We tend to perceive importance of market intelligence and its need in todays competitive world.

Our exhausting team works hard to fetchthe foremostauthentic research reports backed with impeccable data figures that guarantee outstanding resultsanytimefor you.

So, whetheritsthe newestreport from the researchers or a custom requirement, our team is hereto assistyouwithin theabsolute bestway.

Contact Us:

[emailprotected]PH + 1-706-996-2486US Address:225 Peachtree Street NE,Suite 400,Atlanta, GA 30303

Read the rest here:

Nanotechnology Drug Delivery Market 2026 Market Latest Innovations and Trends to Boost Growth With AbbVie, Inc., Amgen Inc., Celgene Corporation,...

Richard said: Manchester is one of the worlds great universities, whose research in many fields, including advanced materials, has international reach. In addition to its national importance, it plays a central role in driving economic growth and prosperity in the city and across the North of England. This is an exciting time to join The University of Manchester and Im looking forward to being part of this important work.

Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester said: Richard is a greatly respected materials physicist who has also made very significant contributions to major national and international activities and to the areas of regional economic growth, productivity and prosperity. I am delighted that he will be joining us.

Professor Martin Schrder, Vice President and Dean of the Universitys Faculty of Science and Engineering, added: I am thrilled and delighted to welcome Professor Richard Jones to the University.

Richard is a renowned experimental physicist with a focus on materials science, specialising in the properties at surfaces and interfaces. Richard has wider interestsin the social and economic consequences of nanotechnology and has contributed significantly to innovation within the higher education sector. I very much look forward to working with Richard and developing and delivering new initiatives across science and engineering.

Richard has a personal blog and is also active on Twitter.

Read more:

New Chair in Materials Physics and Innovation Policy - The University of Manchester